TI
CLBT icon

Trexquant Investment’s Cellebrite CLBT Stock Holding History

Trexquant Investment’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-53,895
Closed -$972K – 1791
2025
Q4 		$972K Buy
+53,895
New +$968K 0.01% 1193
2025
Q2 		– Sell
-296,871
Closed -$5.77M – 1561
2025
Q1 		$5.77M Buy
296,871
+69,273
+30% +$1.46M 0.07% 442
2024
Q4 		$5.01M Sell
227,598
-51,759
-19% -$996K 0.06% 525
2024
Q3 		$4.7M Buy
279,357
+162,777
+140% +$2.42M 0.06% 500
2024
Q2 		$1.39M Sell
116,580
-279,564
-71% -$3.12M 0.02% 882
2024
Q1 		$4.39M Buy
396,144
+134,395
+51% +$1.37M 0.09% 350
2023
Q4 		$2.27M Buy
261,749
+195,841
+297% +$1.52M 0.05% 507
2023
Q3 		$504K Buy
65,908
+49,782
+309% +$374K 0.01% 1018
2023
Q2 		$116K Buy
+16,126
New +$94K ﹤0.01% 1367

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Trexquant Investment's CLBT Position: Q1 2026 in Review

Trexquant Investment sold out of Cellebrite (CLBT) in Q1 2026, closing a stake of 53,895 shares — an estimated $972K sold.

Trexquant Investment first reported a position in CLBT in Q2 2023 and held it in 9 quarters. The position peaked at $5.77M in Q1 2025. 221 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Trexquant Investment reported no remaining Cellebrite position as of Q1 2026 after selling out during the quarter.
  • Trexquant Investment sold 53,895 Cellebrite shares in Q1 2026, an estimated $972K.
  • Trexquant Investment first reported a position in Cellebrite in Q2 2023 and held it in 9 quarters.
  • Trexquant Investment's Cellebrite position peaked at $5.77M in Q1 2025.
  • 221 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.